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BRIEF DEFINITIVE REPORT
        After acute HIV infection, CD8  +   T cell responses 
contribute to control of viral replication and 
suppress viral loads to an individual set point 
(  1, 2  ). Their ability to delay progression to AIDS 
is strongly associated with specifi  c HLA class I 
alleles such as HLA-B57 or -B27 (  3  ), which are 
known to restrict vigorous immunodominant 
CD8 responses during acute infection against 
specifi  c regions of HIV (  4  ). Escape from these 
CD8 responses is associated with a loss of control 
of viremia, indicating that immune control in 
such cases can be primarily mediated by a single 
dominant response (  5  –  7  ). In the case of HLA-
B27, viral control has been strongly associated 
with responses against the immunodominant 
KK10 epitope (KRWIILGLNK) in p24 Gag, 
which may exhibit a unique ability to suppress 
viral replication (  6, 7  ). 
  The strong antiviral activity of KK10-spe-
cifi  c CD8 responses might be caused by their 
ability to eff  ectively recognize early viral escape 
variants. Viral escape typically develops rapidly in 
the KK10 epitope through a position six L  268  M 
escape mutation (  7  ). However, de novo variant-
specifi  c CD8 responses against the L  268  M escape 
variant are commonly mounted (  8, 9  ), which 
eventually leads to the subsequent selection of 
the more potent position 2 escape mutation 
(R  264  K) that is associated with the eventual loss 
of viral control late in chronic infection (  7, 10, 11  ). 
Therefore, variant-specifi  c responses may play 
an important role in the control of HIV, en-
abling prolonged recognition of escaped vi-
ruses (  12, 13  ). Unfortunately, the vast diversity 
of HIV-specifi  c CD8 responses in infected sub-
jects, and the progressive viral escape from these 
responses, has made it diffi   cult to determine the 
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  After acute HIV infection, CD8  +   T cells are able to control viral replication to a set point. 
This control is often lost after superinfection, although the mechanism behind this remains 
unclear. In this study, we illustrate in an HLA-B27  +   subject that loss of viral control after 
HIV superinfection coincides with rapid recombination events within two narrow regions of 
Gag and Env. Screening for CD8  +   T cell responses revealed that each of these recombination 
sites (    50 aa) encompassed distinct regions containing two immunodominant CD8 epitopes 
(B27-KK10 in Gag and Cw1-CL9 in Env). Viral escape and the subsequent development of 
variant-specifi  c de novo CD8  +   T cell responses against both epitopes were illustrative of the 
signifi  cant immune selection pressures exerted by both responses. Comprehensive analysis 
of the kinetics of CD8 responses and viral evolution indicated that the recombination 
events quickly facilitated viral escape from both dominant WT- and variant-specifi  c re-
sponses. These data suggest that the ability of a superinfecting strain of HIV to overcome 
preexisting immune control may be related to its ability to rapidly recombine in critical 
regions under immune selection pressure. These data also support a role for cellular im-
mune pressures in driving the selection of new recombinant forms of HIV. 
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cation after a peak viremia of 468,000 copies/ml (  Fig. 1  ).   As 
early as day 22 after presentation, the dominant CD8 response 
was directed against the KK10 epitope (85 Spot Forming 
Cells/Mio. [SFC/Mio.]) as measured by IFN-     ELISpot as-
say (  Table I  ).   Only six other CD8 responses were detected by 
day 419, with the KK10 response remaining the most immuno-
dominant (  Table I  ). Viral sequencing revealed escape in this 
epitope through the stereotypic CTL escape mutation L  268  M, 
which fi  rst developed at day 419 (T3) coincident with a 
decline in the KK10 WT-specifi  c response (  Fig. 2 A   and 
Fig. S1, available at http://www.jem.org/cgi/content/full/jem
.20080281/DC1).   Viral escape coincided with an initial rise 
of viral loads to 14,000 copies/ml (  Fig. 1  ), suggesting that loss 
of this key CD8 response may have partially impaired early 
viral containment. However, longitudinal testing revealed the 
subsequent development of an L  268  M variant-specifi  c response, 
which expanded substantially by day 419 (  Fig. 2 A  ). These 
data support not only an important contribution of the B27-
KK10 response to early control of HIV, but also a role for 
variant-specifi  c CD8 responses in limiting the impact of this 
early escape mutation (  13  ). 
  Functionality of WT and variant-specifi  c CD8 responses 
  Various studies suggest that the polyfunctionality of a CD8 
response may be a critical indicator of vital eff  ector functions 
and the ability of CD8 responses to actively impair HIV rep-
lication (  23  ). Moreover, Almeida et al. have correlated the 
superior control of HIV replication in subjects expressing 
HLA-B27 with the polyfunctional capacity of the KK10-spe-
cifi  c response (  24  ). To further determine the role of the WT- 
and L  268  M-specifi  c B27-KK10 CD8 responses, we examined 
the polyfunctionality of these responses by assessing fi  ve ef-
fector functions, including IFN-    , IL-2, TNF-    , MIP-1    , 
and CD107a expression by multiparameter fl  ow cytometry. 
relative importance of particular responses and escape muta-
tions, either singly or collectively, on viral containment and 
disease progression. 
  The ability of the immune system to contain viral replica-
tion is also substantially impacted after HIV superinfection. 
Numerous cases of superinfection have been identifi  ed, usu-
ally on the basis of a sudden increase in viral loads (  14  –  17  ). A 
dramatic shift in the immunodominance patterns of CD8 re-
sponses before and after superinfection has also been observed 
(  14  ); this shift may be related to the transmission of mutations 
within targeted CD8 epitopes. Although new CD8 responses 
arise after superinfection, control over viral replication is of-
ten lost (  14  –  16  ), and the factors contributing to the inability 
of preexisting immune responses to contain the superinfect-
ing strain have as yet not been identifi  ed. 
  HIV superinfection may also enable recombination between 
two diff  erent strains (  17  ), which could facilitate evasion of 
host immune responses. Recent data suggest that circulating 
recombinant forms (CRFs) of HIV may be far more com-
mon than previously observed (  18  ). New CRFs may have a 
critical impact on vaccine design as they continue to expand 
the extensive global diversity of HIV (  19  ). Equally problematic 
is that there appears to be little or no pattern to the selection 
of recombination sites within CRFs (  15, 20  ) and the forces 
governing recombination (  15, 21  ). 
  In this study, we provide a comprehensive analysis of 
the forces dictating HIV recombination after superinfection, 
which rapidly lead to the dramatic loss of viral containment 
in a subject expressing the otherwise protective MHC class I 
allele HLA-B27. 
    RESULTS AND DISCUSSION   
  Loss of control of viral replication in the setting 
of HLA-B27 
  Control of HIV in the presence of HLA-B27 (  6, 7, 11, 22  ) 
has been attributed to the early and immunodominant target-
ing of a highly conserved CD8 epitope (KK10; KRWIIL-
GLNK) in Gag. The HLA-B27  +   subject AC160, identifi  ed 
during primary HIV infection, rapidly controlled viral repli-
    Figure 1.     Loss of viral control in subject AC160.  Longitudinal  as-
sessment of plasma viral loads (red line) and CD4  +   T cell counts (dashed 
blue line) after acute HIV-1 infection. At day 503 (T4), viral loads dramati-
cally increased to 380,000 copies/ml, followed by a steady decline in CD4  +  
T cell counts to   <  300 copies/   l.   
    Table I.       CD8  +   T cell responses after superinfection and 
recombination 
Epitope Protein Sequence 22 d
(SFC/
Mio.)
419 d
(SFC/
Mio.)
1,160 d  a 
(SFC/
Mio.)
B27-KK10 p24 KRWIILGLNK 85 830 250
B27-VL9 Vpr VRHFPRIWL - 550 920
B7-IL9 gp41 IPRRIRQGL - 480 -
A2-AL9 Vpr AIIRILQQL - 310 -
Cw1-CL9 gp120 CAPAGFAIL - 240 180
B27-IK9 p17 IRLRPGGKK - 230 960 
Cw7-RY11 Nef RRQDILDLWIY - 160 70 
A1-YT9 Nef YFPDWQNYT - - 1,440
B7-RL9 Nef RPMTYKAAL - - 1,330 
Cw1-VL8 p24 VIPMFSAL - - 1,200 
B7-TL10 Nef TPGPGVRYPL - - 1,070 
B7-RV9 Nef RPMTYKAAV - - 1,040 
A2-SAV10 gp41 SLLNATAIAV - - 980 
  a  6 of the strongest responses, out of a total of 16 new responses developing after 
superinfection, are shown.JEM VOL. 205, August 4, 2008  1791
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but is signifi  cantly down-regulated in subjects exhibiting 
low viral loads or those under antiretroviral therapy (  25, 26  ). 
Therefore, because it may also be interpreted as an indirect 
marker of antigen recognition, we assessed the expression of 
PD-1 on tetramer-specifi  c CD8 cells for the WT KK10 
and L  268  M-specifi  c KK10 responses. Interestingly, both re-
sponses revealed similar levels of T cell exhaustion (median 
fl  uorescent intensity, WT KK10 530 vs. L  268  M 518; unpub-
lished data). Collectively, these data support that both the 
WT and L  268  M-specifi  c CD8 responses are actively recogniz-
ing infected cells, and, in concert, exhibiting immune selec-
tion pressures against both forms of the B27-KK10 epitope. 
More importantly, they suggest that functional variant-specifi  c 
After the L  268  M-specifi  c CD8 response was fi  rst detectable 
(day 363), it substantially increased in polyfunctional capac-
ity, reaching a similar polyfunctional profi  le compared with 
the WT KK10 response (day 545). Both the WT and variant-
specifi  c responses exhibited comparable polyfunctional capac-
ities over time ( Fig. 2 B ), which were not signifi  cantly statistically 
diff  erent from one another. To exclude possible cross recogni-
tion between the WT and L  268  M-specifi  c responses, we assessed 
their antigen-specifi  city in a dual-tetramer staining experiment 
(  Fig. 2 C  ), confi  rming two distinct responses with no detectable 
cross-reactivity. 
  The cell surface marker for exhaustion programmed death-1 
(PD-1) is up-regulated in CD8  +   T cells under high antigen load, 
    Figure 2.         Loss of the immunodominant HLA-B27  –  restricted KK10 CD8 response after viral escape, and the development of a variant-spe-
cifi  c response.   (A) Longitudinal assessment of the WT (black) and L  268 M  variant-specifi  c (gray) KK10 CD8 responses by IFN-     ELISpot. The WT response 
declined at day 419, coincident with development of the L  268  M mutation, after which the L  268 M-specifi  c response developed. Decline of both responses 
occurred at day 1,034 after development of the R  264  K anchor mutation. (B) Assessment of CD8  +   T cell polyfunctionality at four different time points. All 
32 possible combinations of the 5 antigen-specifi  c functions studied for each epitope are shown on the x axis, and the contributions of each epitope-
specifi  c CD8  +   T cell population are indicated as bars (WT, red; L  268  M, blue). Responses are grouped according to the number of functions (1, yellow; 2, 
cyan; 3, green; 4, blue; 5, red) and summarized by pie charts. (C) Dual tetramer staining for the KK10 WT and L  268 M-specifi  c response on day 664, illustrat-
ing two distinct non  –  cross-reacting populations of antigen-specifi  c cells.     1792 IMMUNE DRIVEN RECOMBINATION OF HIV   | Streeck et al. 
second strain of HIV.   The second strain then dominated 
over the nearly 3 yr of follow up, with no subsequent de-
tection of the original infecting strain (unpublished data). 
The shift within the immunodominance pattern of CD8 
responses over this same time frame supported this change 
in the circulating virus (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20080281/DC1). Remarkably, 
fi  ve of the seven CD8 responses present before superinfection 
subsequently declined, whereas other novel CD8 responses 
became immunodominant. A comparison of viral sequences 
revealed that the superinfecting strain transmitted mutations 
in fi  ve of the seven initially targeted epitopes (Table S1). 
Similar changes in the patterns of CD8 responses after super-
infection have been previously described (  14  ), suggestive of a 
  responses may be contributing to the control of viral repli-
cation by tempering the impact of early CTL escape muta-
tions (  13  ). 
  Superinfection is associated with loss of viral control 
  Development of the R  264  K escape mutation in B27-KK10 
nearly completely abrogates binding of the epitope to HLA-
B27 (  11  ) and has been correlated to a dramatic loss of con-
trol over viral replication (  6, 7, 11  ). However, when viral 
loads rapidly increased to 380,000 copies/ml at day 503 
(T4), this specifi  c mutation was notably absent. Rather, a 
phylogenetic analysis revealed that the virus present at day 
503, in fact, represented a distinct strain of HIV (  Fig. 3 A   
and Fig. S1), which is indicative of superinfection with a 
    Figure 3.         Superinfection and recombination.   (A) HIV   gag   sequences from subject AC160 and 19 other HIV chronic-infected subjects were compared 
using a neighbor-joining phylogenetic tree. Sequences from subject AC160 derived from the fi  rst year of infection (days 22, 83, and 419) cluster indepen-
dently from sequences derived later in infection (days 503 and 545). Scale bar indicates the genetic distance along the branches, and bootstrap values 
  >  60 are shown. (B) SimPlot recombination analysis of a full-length HIV sequence derived from day 545 compared with viruses derived from pre-superin-
fection (day 83, green; day 419, red) and the superinfecting strain (day 503, blue) using a window of 100 bp and a step size of 10 bp. Two regions with 
double recombination breakpoints were observed in Gag and Env and Yates-corrected     2   values, and P values were calculated for each putative break-
point. Breakpoints in   gag   were detected around positions 690 (     = 5.8; P = 0.0165) and 822 (     = 50.1; P   <   0.0001), and breakpoints in   env   were  detected 
around positions 6,047 (     = 50.1; P   <   0.0001) and 6,164 (     = 30.1; P   <   0.0001). By day 860 (T8), the breakpoints in   gag   were no longer detectable, sup-
portive of a possible second recombination event in the recombinant strain that restored this region of the original superinfecting strain. (C) Longitudinal 
amino acid alignment of Gag sequences in AC160. Sequences derived from the primary infecting strain (black), the superinfecting strain (red), and the 
new recombinant form (blue) are aligned to clade B consensus. Early viral escape was observed in the B27-KK10 epitope boxed in red. Flanking sequences 
are deleted (//) to illustrate sequence diversity between the two strains. Sequences suggested to be involved in the fi  rst recombination event are shaded 
gray, whereas those involved in the second recombination event are shaded yellow. (D) Longitudinal amino acid alignment of Env sequences containing 
the Cw1-CL9 epitope are boxed in red  .   Sequences suggested to be involved in the third recombination event in Env are shaded gray.     JEM VOL. 205, August 4, 2008  1793
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stantially impair the recognition of both the WT- and L  268  M-
specifi  c responses (  6, 7  ) and normally requires the specifi  c 
compensatory mutation S  173  A (  11  ). In subject AC160, how-
ever, the S  173  A mutation did not arise, but rather two other 
distinct mutations (T  239  V and N  252  S) accompanied R  264  K. 
As we have previously observed the development of R  264  K in 
conjunction with other rare mutations in its proximity (  22  ), 
it is likely that one or both of these mutations serve to com-
pensate for the fi  tness defect of R  264  K. Therefore, develop-
ment of R  264  K through recombination was likely facilitated 
by suitable compensatory mutations developing within the 
backbone sequence of the superinfecting strain rather than 
within the original infecting strain. 
  This development of R  264  K resulted in the impaired recog-
nition of both WT and variant-specifi  c responses as indicated 
by their decline by day 1,034 (T9;   Fig. 2 A  ). Interestingly, 
although the L  268  M-specifi  c response was dominant and of 
higher functional avidity than the WT KK10 response before 
the fi  rst recombination event, both the WT and L  268  M re-
sponses were co-dominant and of similar functional avidity at 
day 664 (T6) before this second recombination event (1,334 
SFC/Mio. and logIC  50       0.04 vs. 1,450 SFC/Mio. and logIC  50   
    0.04, respectively;   Fig. 2 A  ). Therefore, at the time the 
R  264  K mutation developed in conjunction with a likely second 
recombination event, both the WT and the variant-specifi  c re-
sponses were eliciting similar immune selection pressure. 
  Recombination in envelope 
  To determine whether recombination at sites of strong im-
mune selection pressure might represent a more common 
phenomenon to escape potent CD8 responses after superin-
fection, full-length viral genome sequences from nine time 
points over the course of infection were compared. Only one 
other recombination event of     40 aa in length was detected 
across the whole viral genome. This small recombination 
event between aa 220 and 260 of envelope arose at day 545 
(T5), at the same time as the fi  rst recombination event in 
KK10 (  Fig. 3 B  ). This region resides outside of the V3 loop of 
the virus, and no switch in the co-receptor tropism was 
detected using the geno2pheno method (  27  ). Notably, this 
short region of recombination contained one of the other 
six CD8 epitopes targeted before superinfection, namely the 
Cw1-CL9 epitope CAPAGFAIL (  Table I   and   Fig. 4  ).   Similar 
to the KK10 response, this Cw1-restricted response exerted 
immune selection pressure against the virus as indicated by 
early viral escape through an A  217  T mutation developing at 
day 419 (T3) that was shown to impair T cell recognition 
(  Fig. 3 D   and not depicted). As superinfection had resulted 
in transmission of the WT form of the Cw1-CL9 epitope, 
the subsequent recombination event at day 545 (T5) rapidly 
replaced this region with a sequence containing the A  217  T 
escape mutation derived from the virus circulating at day 419 
(T3;   Fig. 3 D  ). Thus, viral escape in this epitope after su-
perinfection was also accomplished through recombination 
rather than through a single amino acid substitution. Simi-
lar to the KK10 epitope, an A  217  T variant-specifi  c response 
potentially critical role for transmitted mutations in the eva-
sion of CD8 responses and enabling outgrowth of the new 
incoming strain. 
  Viral recombination in regions under strong immune 
selection pressure 
  Despite the documented importance of the KK10-specifi  c 
CD8 response, unexpectedly, there was no sequence evolu-
tion observed in the KK10 epitope at the time of superinfec-
tion. Rather the same preexisting L  268  M escape mutation was 
present in the superinfecting strain. Surprisingly, however, 
only 2 mo after superinfection (day 545), we observed an un-
characteristic reversion of the L  268  M mutation to the WT se-
quence in addition to other sequence changes surrounding 
KK10 (Fig. S1). Strikingly, the comparison of longitudinal 
sequences revealed a short recombination event in Gag be-
tween the original and superinfecting strain at day 545 (T5; 
  Fig. 3 B  ), which resulted in substitution of a narrow region of 
Gag from the original strain between amino acid residues 220 
and 274 within the superinfecting strain (  Fig. 3 C  ). This short 
region overlapped with the B27-KK10 epitope and resulted 
in an unusual replacement of the L  268  M mutation with the 
WT form present during acute infection. To evaluate whether 
immune selection pressures might have infl  uenced this re-
combination event, we examined the WT and variant-specifi  c 
KK10 CD8 responses at the time of superinfection. Longitu-
dinal analysis of IFN-     ELISpot responses revealed that at 
the time of superinfection the L  268  M-specifi  c response was 
actually substantially stronger (1528 SFC/Mio.), and also of 
higher avidity (IC  50       0.26   μ  g/ml; not depicted), than the WT-
specifi  c response (531 SFC/Mio.; IC  50       0.88   μ  g/ml;   Fig. 2 A  ). 
Therefore, in the setting of a substantially stronger L  268  M-
specifi  c response at day 503, substitution of this region con-
taining the L  268  M mutation with the WT form of the epitope 
would have facilitated evasion from a stronger L  268  M-specifi  c 
response. Supportive of this hypothesis, levels of the L  268  M-
specifi  c response subsequently declined by as early as day 664 
(T6;   Fig. 2 A  ). These data suggest that a recombination event 
in a narrow region of Gag within 2 mo of superinfection 
facilitated rapid escape from the dominant variant-specifi  c 
KK10 response. 
  Transient regain of viral control is lost through development 
of a second recombination event in Gag 
  After recombination to the WT sequence, viral loads de-
clined under the presence of a WT KK10-specifi  c CD8 re-
sponse to 20,000 copies/ml by day 762, but then rebounded 
again to 139,000 copies/ml at day 860 (T8;   Fig. 1  ). Viral se-
quences in the KK10 epitope at this later time point illus-
trated development of the R  264  K escape mutation (  Fig. 3 C  ). 
Moreover, these sequences revealed the likely occurrence of 
a second recombination event having again substituted a short 
sequence surrounding KK10 and facilitating development of 
the R  264  K mutation (  Fig. 3 C  ), although the narrow length of 
this second recombination event precluded a critical analysis 
of breakpoints. The R  264  K mutation has been shown to sub-1794 IMMUNE DRIVEN RECOMBINATION OF HIV   | Streeck et al. 
strain to overcome immune control may be related to its ability 
to rapidly recombine in critical regions under immune selec-
tion pressure. These data also support a critical role for cellu-
lar immune pressures in driving the selection of recombination 
break points, thus contributing to the selection of new circu-
lating recombinant forms of HIV. 
    MATERIALS AND METHODS   
  Subjects.     The HLA-B27  +   subject AC160, identifi  ed during primary HIV 
infection, and 19 other chronically infected control subjects, were enrolled 
at Massachusetts General Hospital in Boston. The study was approved by the 
institutional review board of the Massachussetts General Hospital. 
  Sequencing of autologous virus.     Population sequences of autologous 
full-length viral genomes were derived from proviral DNA, as previously 
described (  13  ). In brief, genomic DNA extracted from 5 million PBMCs 
using the QIAamp DNA Blood Mini kit (QIAGEN). Nested PCR proto-
cols with limiting dilution used to amplify full-length HIV genomes using 
EXL DNA Polymerase (Stratagene). The sequences of primary forward and 
reverse PCR primers, respectively, are 5    -AAATCTCTAGCAGTGGC-
GCCCGAACAG-3     and 5    -TGAGGGATCTCTAGTTACCAGAGTC-3    , 
whereas the nested forward and reverse primers are 5    -GCGGAGGC-
TAGAAGGAGAGAGATGG-3     and 5   -GCACTCAAGGCAAGCTTTA-
TTGAGGCTTA-3    . PCR cycling conditions were as follows: 92  °  C for 
2 min; 10 cycles of 10 s at 92  °  C, 30 s at 60  °  C, or 10 min at 68  °  C; and 20 cycles 
of 10 s at 92  °  C, 30 s at 55  °  C, 10 min at 68  °  C, and a fi  nal extension of 
10 min at 68  °  C. Five independent PCR products of each sample were 
pooled and purifi  ed using the QIAquick PCR Purifi  cation kit (QIAGEN) 
and population sequenced bi-directionally on an ABI 3130 automated sequencer 
(Applied Biosystems) using 70 clade B consensus sequencing primers, as pre-
viously described (  14  ). 
  Autologous clonal   gag   and   env   sequences were derived from plasma 
RNA, as previously described (  13  ). Viral RNA was isolated from plasma, 
and nested PCR was conducted using a set of described primers specifi  c for 
HIV (  14  ). First round PCR cycling conditions were as follows: 94  °  C for 2 
min, 35  –  50 cycles of 30 s at 94  °  C, 30 s at 56  °  C, 2 min at 72  °  C, and a fi  nal 
extension of 68  °  C for 20 min, and nested PCR reactions were shortened to 
a 1-min extension time. PCR fragments were then gel purifi  ed and se-
quenced directly or cloned (TOPO TA Cloning kit; Invitrogen). Plasmid 
DNA was isolated by miniprep (QIAPrep Turbo Miniprep) and sequenced 
bi-directionally. 
  Sequence data were manually edited using Sequencher 4.6 (Gene Codes 
Corporation). In regions where secondary peaks were observed, the domi-
nant base was called. Nucleotide sequences were conceptually translated and 
aligned using MacVector 7.2.3 (Accelrys). The clade B HIV consensus se-
quence (2002) from Los Alamos National Laboratory HIV Sequence Data-
base was used as the reference sequence to compare with our sequencing 
data. All sequence data were deposited in GenBank under accession nos. 
  EU616639    –    EU616649  . 
  Phylogenetic analysis.       Gag   sequences from subject AC160 were aligned 
and compared with sequences derived from chronically infected subjects 
within a chronic infection cohort in Boston using Phylip3.6 for constructing 
neighbor-joining phylogenetic tree. 
  Recombination.     Recombination break points were determined using 
SimPlot (see Supplemental materials and methods and Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20080281/DC1). Full-length 
HIV sequences were analyzed using a 100-bp window and a 10-bp step 
size, and Yates-corrected       2   values and P values were calculated for each pu-
tative breakpoint. 
  ELISpot.     Baseline HIV-specifi  c CD8  +   T cell responses were quantifi  ed on 
freshly isolated PBMCs by IFN-     ELISpot assay (  4  ) using 410 overlapping 
developed, peaking at day 545 (  Fig. 4  ; T5, 730 SFC/Mio.), 
with the development of additional mutations in this epit-
ope by day 1,034 (  Fig. 3 D  ) observed to completely abrogate 
both the WT and variant-specifi  c responses (  Fig. 4  ). Collec-
tively, these data revealed the presence of a third recombina-
tion event associated with evasion of a CD8 response, which 
is strongly indicative of successive attempts by the virus to 
rapidly evade dominant immune selection pressures directly 
through recombination. 
  It has been recently suggested that recombination after 
HIV superinfection occurs more frequently than anticipated 
(  28  ). Understanding the underlying mechanisms of recombi-
nation pertains not only to the impact of greater global HIV 
diversity (  15  ), but also to the critical events undermining 
successful immune control of HIV infection. The generation 
of HIV recombinants is thought to occur by a copy choice 
mechanism during reverse transcription (  20  ), with breakpoint 
selection generally being a random event, although it is infl  u-
enced by sequence identity (  20, 21  ). These data indicate that 
recombination enabled rapid evasion from the most immuno-
dominant CD8 response in subject AC160, strongly suggest-
ing that the recombination event was driven by immune 
selective pressures. 
  The current study indicates that specifi  c selection forces, 
in this case cellular immune pressures, can strongly infl  uence 
recombination. The diversity of HLA class I alleles in the 
population, and the variety of CD8 responses, would explain 
the complex array of recombination breakpoints between 
diff  erent HIV strains observed to date (  19  ) and the inability to 
ascribe a strong predictor of recombination hotspots. In con-
clusion, these data suggest that the ability of a superinfecting 
    Figure 4.         Abrogation of the Cw1-CL9 response after recombina-
tion in Env.   Longitudinal development of the WT (black) and A  217 T  vari-
ant-specifi  c (gray) CL9 responses as measured by IFN-     ELISpot. The A  217 T 
variant-specifi  c response was not detected before recombination at day 
419 (  ”  not present  ”  ). At the time of superinfection at day 503, the WT re-
sponse exhibited the highest magnitude, suggestive of having driven the 
recombination event to the A  217  T form of CL9. Decline of both the WT and 
the A  217 T  -specifi  c CL9 response was observed at day 1,034.     JEM VOL. 205, August 4, 2008  1795
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